All Posts:genetic testing
-
Rise in Claim Denial Rates for Cancer-Related Advanced Genetic Testing
A newly published analysis by Georgetown Lombardi member So-Yeon Kang, PhD, MBA, and colleagues has found that both the use of next-generation sequencing (NGS) testing for cancer and the rate of claim denials for such testing increased between 2016 and 2021, despite implementation of a recent Medicare national coverage determination that established coverage standards for NGS testing. Read more about this research.
Category: News Release
-
$3.2 Million Grant Supports Study of New Genetic Testing Approach to Reduce Racial Health Disparities
The National Cancer Institute has awarded a $3.2 million grant to investigators from Georgetown University’s Lombardi Comprehensive Cancer Center and Rutgers Cancer Institute of New Jersey, both NCI-designated Comprehensive Cancer Centers, to examine a novel approach to genetic testing and care based on community-identified needs, with the aim of reducing racial disparity gaps in cancer care delivery.
Category: News Release
-
Informing Children of a Mother’s Genetic Cancer Risk Does Not Impact Their Health Behaviors
WASHINGTON (July 21, 2022) — Telling a child about their mother’s risk of hereditary breast and ovarian cancer does not adversely influence the offspring’s lifestyle or quality of life in the long term, according to a new study led by researchers at Georgetown Lombardi Comprehensive Cancer Center. The finding appeared July 21, 2022, in Pediatrics […]
Category: News Release
-
MRI May Lower Breast Cancer Deaths From Variants in Three Genes
Variants in these genes are as prevalent as the BRCA1/2 mutations. An analysis suggests annual MRI starting at age 30-35 would cut cancer mortality by 50%. WASHINGTON (February 17, 2022) — Annual MRI screenings starting at ages 30 to 35 may reduce breast-cancer mortality by more than 50% among women who carry certain genetic changes […]
Category: News Release
-
Cancer Genetic Counseling in the Time of COVID-19
Category: Lombardi Stories
-
Cancer Organization Recommends Genetic Testing for Jewish People of Ashkenazi Descent
(January 28, 2020) — New guidelines from a leading cancer organization have broadened criteria for hereditary cancer genetic testing. The change means more people who could be at increased risk of developing cancer should consider being tested. The guidelines, released in December 2019 by the National Comprehensive Cancer Network, now indicate that all adult Ashkenazi […]
Category: Lombardi Stories
-
Be a Family Detective This Holiday Season
(November 14, 2019) — As the leaves fall through crisp autumn air, many of us are beginning to prepare for Thanksgiving and the start of the holiday season. But did you know that Turkey Day is also National Family History Day? If discussing politics and climate change isn’t your thing, consider squeezing in a little detective work […]
Category: Lombardi Stories
-
Gene Test to Predict Breast Cancer Recurrence Less Cost Effective in Real World Practice
A team of researchers led by Georgetown Lombardi Comprehensive Cancer Center has published a study that indicates that the most commonly used gene expression profile test used to help predict breast cancer recurrence may not be as cost-effective as once thought.
Category: News Release